Management of glomerular proteinuria: a commentary - PubMed
Review
Management of glomerular proteinuria: a commentary
William A Wilmer et al. J Am Soc Nephrol. 2003 Dec.
Abstract
It is widely accepted that proteinuria reduction is an appropriate therapeutic goal in chronic proteinuric kidney disease. Based on large randomized controlled clinical trials (RCT), ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB) therapy have emerged as the most important antiproteinuric and renal protective interventions. However, there are numerous other interventions that have been shown to be antiproteinuric and, therefore, likely to be renoprotective. Unfortunately testing each of these antiproteinuric therapies in RCT is not feasible. The nephrologist has two choices: restrict antiproteinuric therapies to those shown to be effective in RCT or expand the use of antiproteinuric therapies to include those that, although unproven, are plausibly effective and prudent to use. The goal of this work is to provide the documentation needed for the nephrologist to choose between these strategies. This work describes 25 separate interventions that are either antiproteinuric or may block injurious mechanisms of proteinuria. Each intervention is assigned a level of recommendation (Level 1 is the highest; Level 3 is the lowest) according to the strength of the evidence supporting its antiproteinuric and renoprotective efficacy. Pathophysiologic mechanisms possibly involved are also discussed. The number of interventions at each level of recommendation are: Level 1, n = 7; Level 2, n = 9; Level 3, n = 9. Our experience indicates that we can achieve in most patients the majority of Level 1 and many of the Level 2 and 3 recommendations. We suggest that, until better information becomes available, a broad-based, multiple-risk factor intervention to reduce proteinuria can be justified in those with progressive nephropathies. This work is intended primarily for clinical nephrologists; therefore, each antiproteinuria intervention is described in practical detail.
Comment in
-
Regarding: "Management of glomerular proteinuria: a commentary".
Brenner BM. Brenner BM. J Am Soc Nephrol. 2004 May;15(5):1354-5; discussion 1356-7. J Am Soc Nephrol. 2004. PMID: 15100378 Review. No abstract available.
Similar articles
-
Renoprotection: one or many therapies?
Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS Jr, Rovin BH. Hebert LA, et al. Kidney Int. 2001 Apr;59(4):1211-26. doi: 10.1046/j.1523-1755.2001.0590041211.x. Kidney Int. 2001. PMID: 11260381 Review.
-
Renal damage associated with proteinuria.
Praga M, Morales E. Praga M, et al. Kidney Int Suppl. 2002 Dec;(82):S42-6. doi: 10.1046/j.1523-1755.62.s82.9.x. Kidney Int Suppl. 2002. PMID: 12410854 Review.
-
Esnault VL, Ekhlas A, Nguyen JM, Moranne O. Esnault VL, et al. Nephrol Dial Transplant. 2010 Jul;25(7):2218-24. doi: 10.1093/ndt/gfp776. Epub 2010 Jan 26. Nephrol Dial Transplant. 2010. PMID: 20106824 Clinical Trial.
-
Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G. Catapano F, et al. Am J Kidney Dis. 2008 Sep;52(3):475-85. doi: 10.1053/j.ajkd.2008.03.008. Epub 2008 May 12. Am J Kidney Dis. 2008. PMID: 18468748
Cited by
-
Medaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy.
Ichimura K, Kawashima Y, Nakamura T, Powell R, Hidoh Y, Terai S, Sakaida I, Kodera Y, Tsuji T, Ma JX, Sakai T, Matsumoto H, Obara T. Ichimura K, et al. Biochem Biophys Res Commun. 2013 Feb 22;431(4):712-7. doi: 10.1016/j.bbrc.2013.01.053. Epub 2013 Jan 23. Biochem Biophys Res Commun. 2013. PMID: 23353086 Free PMC article.
-
Szeto CC, Li PK. Szeto CC, et al. NDT Plus. 2009 Jun;2(3):205-12. doi: 10.1093/ndtplus/sfp034. Epub 2009 Mar 24. NDT Plus. 2009. PMID: 25983993 Free PMC article.
-
Hebert LA, Birmingham DJ, Shidham G, Rovin B, Nagaraja HN, Yu CY. Hebert LA, et al. Nephron Clin Pract. 2009;113(3):c177-82. doi: 10.1159/000232599. Epub 2009 Aug 12. Nephron Clin Pract. 2009. PMID: 19672116 Free PMC article.
-
Proteinuria: an enzymatic disease of the podocyte?
Mundel P, Reiser J. Mundel P, et al. Kidney Int. 2010 Apr;77(7):571-80. doi: 10.1038/ki.2009.424. Epub 2009 Nov 18. Kidney Int. 2010. PMID: 19924101 Free PMC article. Review.
-
Qiu H, Fan W, Fu P, Zuo C, Feng P, Liu F, Zhou L, Chen F, Zhong H, Liang Y, Shi M. Qiu H, et al. Afr J Tradit Complement Altern Med. 2013 May 16;10(4):109-15. doi: 10.4314/ajtcam.v10i4.18. eCollection 2013. Afr J Tradit Complement Altern Med. 2013. PMID: 24146510 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous